novo nordisk wegovy news

Novo Nordisk, MASH and Wegovy

Novo Nordisk Says Wegovy Improved Patients’ Liver Disease

Novo Nordisk A/S’s Wegovy helped treat an obesity-associated liver disease in a late-stage trial, potentially adding to its status as a weight-loss medicine that can treat and prevent several other conditions.

STAT · 2d

With new Wegovy data in hand, Novo Nordisk will file for approval in MASH

Novo Nordisk’s Wegovy helped people with a fatty liver disease called MASH experience improvements in liver scarring and achieve symptom resolution, new data show.

Business Insider · 1d

Novo Nordisk’s semaglutide shows superior MASH resolution improvement in trial

Novo Nordisk (NVO) announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial

Becker's Hospital Review · 1d

Semaglutide shows improvement in liver disease treatment in late stage trial

A Novo Nordisk Phase 3 trial found that 37% of adults with metabolic dysfunction-associated steatohepatitis who received once-weekly semaglutide 2.4 milligrams showed improvement in liver fibrosis without worsening steatohepatitis,

3don MSN

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

STAT4d

Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

5don MSN

Novo Nordisk Shares Seen Outpacing Lilly’s After Summer Stumble

Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity drugs ...

Becker's Hospital Review2d

Ozempic, Wegovy shortages resolved: FDA

Previously, the lowest dose of Wegovy, 25 milligrams, was listed as in short supply. Since early 2022, several doses of semaglutide — the active ingredient in Wegovy and Ozempic — had been on the ...

BioSpace3d

FDA Says All Doses of Novo’s Ozempic, Wegovy Now Available

Wednesday’s update to the regulator’s drug shortage database is good news for Novo Nordisk, which has struggled to keep up ...

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from part 1 of the ongoing ESSENCE Phase 3 trial, a 240-week ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Novo Nordisk, MASH and Wegovy

Related topics